SOURCE: Healtheuniverse Inc.

February 27, 2007 09:06 ET

Healtheuniverse Announces Non-Embryonic Adult Stem Cell Technology Approaching Clinical Trials

COVINA, CA -- (MARKET WIRE) -- February 27, 2007 -- Healtheuniverse Inc. (PINKSHEETS: HLUN), a biotechnology development firm engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells, announced today that the Company's non-embryonic stem cell technology is being prepared for clinical trials. The Company has researched and is preparing to submit an application through an Independent Institutional Review Board to pursue a clinical trial for the utilization of fat-based stem cells in the field of plastic and reconstructive surgery. Institutional Review Board (IRB) and other approvals must be received at the initial study sites before opening for enrollment.

Adipose tissue, also known as fat, is an abundant source of stem cells and other regenerative cells that can contribute to the repair and healing of damaged tissue. The first clinical trial and subsequent clinical trials will be focused on growing different cell types from adult stem cells utilizing the Company's proprietary process. Therapies utilizing this process have varied applications but will initially be focused on plastic, cosmetic, and reconstructive surgery. Additional applications in the areas of wound care, orthopedic, vascular, and cardiac surgery are also benchmarked to be pursued.


HEALTHeUNIVERSE Inc. is engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells for use in plastic and reconstructive surgery, orthopedic surgery, vascular surgery, cardiac surgery, and wound care. Healtheuniverse strives to be the first to commercialize the use of regenerative medicine in plastic and reconstructive surgery and to develop therapeutic uses in disease related commercial applications. More information on Healtheuniverse is available online at

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    Healtheuniverse, Inc.
    Investor Relations
    Email Contact